|
MechanismProtease inhibitors |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Shanghai Xingkang Medicine Research Development Co., Ltd.
0 Patents (Medical) associated with Shanghai Xingkang Medicine Research Development Co., Ltd.
100 Deals associated with Shanghai Xingkang Medicine Research Development Co., Ltd.
100 Translational Medicine associated with Shanghai Xingkang Medicine Research Development Co., Ltd.